Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Rifampicin DDI Study in TB (PHENORIF)
NCT04525235Phase 1Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rifampicin in pulmonary tuberculosis (TB) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Area Under the Curve at 24 hours. Started Jan 2021; status: completed.
02
Drugs
rifampicin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT04525235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04525235.